有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 3-[(4-fluorophenyl)methyl]-5-[(1S)-1-(1-prop-2-enyltetrazol-5-yl)sulfanylethyl]-1,2,4-oxadiazole | —— | C15H15FN6OS |
|
—— | 5-Ethylsulfanylpyridazine-3,4-diamine | —— | C6H10N4S |
|
—— | 4-amino-2-[(1S)-1-(5-tert-butyl-1,3-oxazol-2-yl)ethyl]sulfanylpyrimidine-5-carbonitrile | —— | C14H17N5OS |
|
—— | 4-amino-2-[(1R)-1-(5-tert-butyl-1,3-oxazol-2-yl)ethyl]sulfanylpyrimidine-5-carbonitrile | —— | C14H17N5OS |
|
—— | 3-[(4-fluorophenyl)methyl]-5-[(1R)-1-(1-prop-2-enyltetrazol-5-yl)sulfanylethyl]-1,2,4-oxadiazole | —— | C15H15FN6OS |
|
—— | 4-[(1R)-1-(2-fluorophenyl)ethyl]sulfanyl-2H-triazole | —— | C10H10FN3S |
|
—— | 4-[(1S)-1-(2-fluorophenyl)ethyl]sulfanyl-2H-triazole | —— | C10H10FN3S |
|
—— | N-[(1S)-1-(2-hydroxyphenyl)ethyl]-N-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]sulfanylacetamide | —— | C17H17F3N2O2S |
|
—— | N-[(1R)-1-(2-hydroxyphenyl)ethyl]-N-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]sulfanylacetamide | —— | C17H17F3N2O2S |
|
—— | [(E)-2,3-bis(phenylsulfanyl)prop-2-enyl]-dimethylazanium | —— | C17H20NS2+ |
|
—— | N-Cyclohexyldithiocarbamic acid, ammonium salt | —— | C7H15N2S2+ |
|
—— | 2-[(4-Chlorophenyl)sulfanyl]-1-phenyl-1-ethanone oxime | —— | C14H12ClNOS |
|
—— | (Z)-3-[5-(4-chlorophenyl)sulfanylfuran-2-yl]-2-cyano-N-(oxolan-2-ylmethyl)prop-2-enamide | —— | C19H17ClN2O3S |
|
—— | (2S)-3-(4-fluorophenyl)sulfanyl-2-methyl-N-[[(3R)-3-morpholin-4-ylthiolan-3-yl]methyl]propanamide | —— | C19H27FN2O2S2 |
|
—— | N-cyclopropyl-2-[(1S)-1-(2,6-difluorophenyl)ethyl]sulfanyl-5-nitropyrimidin-4-amine | —— | C15H14F2N4O2S |
|
—— | 1-bromo-2-[(2S)-2-methyl-3-methylsulfonylpropyl]sulfanylbenzene | —— | C11H15BrO2S2 |
|
—— | (2R)-3-(4-fluorophenyl)sulfanyl-2-methyl-N-[[(3S)-3-morpholin-4-ylthiolan-3-yl]methyl]propanamide | —— | C19H27FN2O2S2 |
|
—— | 1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(Z)-[(E)-2-methyl-3-phenylprop-2-enylidene]amino]-5-[(4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]triazole-4-carboxamide | —— | C19H19N11O2S |
|
—— | (2R)-3-(4-fluorophenyl)sulfanyl-2-methyl-N-[[(3R)-3-morpholin-4-ylthiolan-3-yl]methyl]propanamide | —— | C19H27FN2O2S2 |
|
—— | 1-bromo-2-[(2R)-2-methyl-3-methylsulfonylpropyl]sulfanylbenzene | —— | C11H15BrO2S2 |
|
—— | (2S)-3-(4-fluorophenyl)sulfanyl-2-methyl-N-[[(3S)-3-morpholin-4-ylthiolan-3-yl]methyl]propanamide | —— | C19H27FN2O2S2 |
|
—— | [(Z)-4-amino-3-cyano-2-oxopent-3-enyl] 3-phenylsulfanylpropanoate | —— | C15H16N2O3S |
|
—— | (4E)-5-{[(4-chlorophenyl)sulfanyl]methyl}-4-[4-(dimethylamino)benzylidene]-2-phenyl-2,4-dihydro-3H-pyrazol-3-one | —— | C25H22ClN3OS |
|
—— | 3-cyclopropyl-5-[(2S)-4-phenylsulfanylbutan-2-yl]sulfanyl-4-prop-2-enyl-1,2,4-triazole | —— | C18H23N3S2 |
|
—— | 3-cyclopropyl-5-[(2R)-4-phenylsulfanylbutan-2-yl]sulfanyl-4-prop-2-enyl-1,2,4-triazole | —— | C18H23N3S2 |
|
—— | N-[(Z)-1-(4-chlorophenyl)ethylideneamino]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide | —— | C16H17ClN4OS |
|
—— | [(E)-2-nitro-2-phenylsulfanylethenyl]benzene | —— | C14H11NO2S |
|
—— | 2-[[5-[(4-methylanilino)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]sulfanyl]-N-[(Z)-1-phenylethylideneamino]acetamide | —— | C23H26N6OS |
|
—— | 5-[(1R)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)ethyl]-3-propan-2-yl-1,2,4-oxadiazole | —— | C16H20N2O3S |
|
—— | 5-[(1S)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)ethyl]-3-propan-2-yl-1,2,4-oxadiazole | —— | C16H20N2O3S |
|
—— | 2-[(5-propan-2-yloxy-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(1S,2S)-2-(trifluoromethyl)cyclohexyl]acetamide | —— | C14H20F3N3O2S2 |
|
—— | prop-2-en-1-yl (2E)-7-methyl-2-(4-methylbenzylidene)-5-[4-(methylsulfanyl)phenyl]-3-oxo-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate | —— | C26H24N2O3S2 |
|
—— | (E)-2-[1-[(E)-1-cyano-2-ethoxyethenyl]sulfonyl-2-ethoxyethenyl]sulfonyl-3-ethoxyprop-2-enenitrile | —— | C14H18N2O7S2 |
|
—— | 1,2-Dichloro-3-isothiocyanato-1-propene | —— | C4H3Cl2NS |
|
—— | 3-phenylsulfanyl-N-[(Z)-1-thiophen-2-ylethylideneamino]propanamide | —— | C15H16N2OS2 |
|
—— | 2-[(5-propan-2-yloxy-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(1R,2S)-2-(trifluoromethyl)cyclohexyl]acetamide | —— | C14H20F3N3O2S2 |
|
—— | (2S)-N-(cyclooctylmethyl)-2-propan-2-ylsulfonylpropanamide | —— | C15H29NO3S |
|
—— | 2-[(5-propan-2-yloxy-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(1S,2R)-2-(trifluoromethyl)cyclohexyl]acetamide | —— | C14H20F3N3O2S2 |
|
—— | 1-[2-(2-methyl-1,2,4-triazol-3-yl)ethyl]-3-[(1R)-1-(4-propan-2-ylsulfanylphenyl)ethyl]urea | —— | C17H25N5OS |
|
—— | 1-[2-(2-methyl-1,2,4-triazol-3-yl)ethyl]-3-[(1S)-1-(4-propan-2-ylsulfanylphenyl)ethyl]urea | —— | C17H25N5OS |
|
—— | (2R)-2-[[4-(2,2,2-trifluoroethyl)-1,2,4-triazol-3-yl]sulfanyl]cyclohexan-1-one | —— | C10H12F3N3OS |
|
—— | 1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(Z)-1-(4-methylphenyl)ethylideneamino]-5-(phenylsulfanylmethyl)triazole-4-carboxamide | —— | C21H20N8O2S |
|
—— | (2S)-2-[[4-(2,2,2-trifluoroethyl)-1,2,4-triazol-3-yl]sulfanyl]cyclohexan-1-one | —— | C10H12F3N3OS |
|
—— | 2-({5-[(4-chlorobenzyl)sulfanyl]-1,3,4-thiadiazol-2-yl}sulfanyl)-N'-[(1Z)-1-(thiophen-2-yl)ethylidene]acetohydrazide | —— | C17H15ClN4OS4 |
|
—— | 2-[[5-[(4-chlorophenyl)methylsulfanyl]-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(Z)-1-(4-fluorophenyl)ethylideneamino]acetamide | —— | C19H16ClFN4OS3 |
|
—— | (E)-4-hydroxy-3-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]pent-3-en-2-one | —— | C8H10N2O2S3 |
|
—— | (3R)-1-propan-2-yl-3-(2H-triazol-4-ylsulfanyl)piperidin-2-one | —— | C10H16N4OS |
|
—— | (3S)-1-propan-2-yl-3-(2H-triazol-4-ylsulfanyl)piperidin-2-one | —— | C10H16N4OS |
|
—— | (2R)-N-cyclopropyl-N-(thiophen-2-ylmethyl)-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C17H17NO2S2 |
|
—— | (2S)-N-cyclopropyl-N-(thiophen-2-ylmethyl)-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C17H17NO2S2 |
|